Proteomics reveals protein shifts in diabetic eye disease
Diabetic retinopathy, DR, is the leading cause of blindness and vision impairment in adults under 40 in developed countries. Many cases progress to vision-threatening stages, including proliferative diabetic retinopathy, PDR, and neovascular glaucoma, NVG. To investigate the molecular mechanisms driving this progression and identify potential biomarkers, Jae Won Oh and colleagues in South Korea used label-free quantification and tandem mass tagging to profile the clear fluid found at the front of the eye, known as aqueous humor, from patients with nonproliferative DR, NPDR, PDR and NVG. Their findings, published in Molecular & Cellular Proteomics, identified proteins that differed across DR stages.
The researchers used triple-quadrupole mass spectrometry to validate the potential biomarker expression, including APOB, TF and S100A7. These proteins showed markedly different expression levels between NPDR and PDR, as well as between PDR and NVG. Between NPDR and PDR, levels of S100A7, a protein linked to inflammation, increased, suggesting an early activation of inflammatory pathways. In contrast, structural lens proteins, more abundant in NPDR, began to decline in PDR, indicating a shift away from tissue maintenance toward stress response. As the disease advanced from PDR to NVG, proteins like APOB and TF, which are involved in fat transport and immune regulation, continued to rise in expression. APOB stood out as a key marker of the most severe stage, NVG, showing a clear increase in levels compared to earlier stages. These shifts in protein expression reflect how the disease moves from affecting eye tissue and vision early on to involving more serious inflammation and damage in the later stages.
These findings provide key insight into the molecular progression of diabetic retinopathy and highlight stage-specific protein changes that could serve as biomarkers. By uncovering potential targets for earlier diagnosis and tailored treatment, this study lays the groundwork for improved management of vision-threatening diabetic eye disease.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Light-activated small molecule could transform eye infection treatment
Contact lenses raise the risk of infectious keratitis, a leading cause of blindness worldwide. A biotech company is commercializing a light-activated therapy using a ROS-generating molecule to rapidly kill microbes in the cornea to preserve vision.
The molecular orchestra of memory
Calcium, calmodulin and calcium/calmodulin-dependent kinase II form a molecular axis that turns fleeting neural activity into lasting memories. New research shows how memories are stabilized, and possibly even protected or repaired.
Differences in pili structure modulate bacterial behavior
Researchers demonstrate how small changes in the structure of hair-like protein appendages can affect the behavior of Acinetobacter bacteria.
Cholesterol regulatory genes predict liver transplant outcomes
Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.
Lipid signatures for a rare neurological disorder
Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.
Disease-linked mutations disrupt protein phase behavior
Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.